Healthcare (Jul 2023)

KIT 1 (Keep in Touch) Project—Televisits for Cancer Patients during Italian Lockdown for COVID-19 Pandemic: The Real-World Experience of Establishing a Telemedicine System

  • Calogero Casà,
  • Barbara Corvari,
  • Francesco Cellini,
  • Patrizia Cornacchione,
  • Andrea D’Aviero,
  • Sara Reina,
  • Silvia Di Franco,
  • Alessandra Salvati,
  • Giuseppe Ferdinando Colloca,
  • Alfredo Cesario,
  • Stefano Patarnello,
  • Mario Balducci,
  • Alessio Giuseppe Morganti,
  • Vincenzo Valentini,
  • Maria Antonietta Gambacorta,
  • Luca Tagliaferri

DOI
https://doi.org/10.3390/healthcare11131950
Journal volume & issue
Vol. 11, no. 13
p. 1950

Abstract

Read online

To evaluate the adoption of an integrated eHealth platform for televisit/monitoring/consultation during the COVID-19 pandemic. Methods: During the lockdown imposed by the Italian government during the COVID19 pandemic spread, a dedicated multi-professional working group was set up in the Radiation Oncology Department with the primary aim of reducing patients’ exposure to COVID-19 by adopting de-centralized/remote consultation methodologies. Each patient’s clinical history was screened before the visit to assess if a traditional clinical visit would be recommended or if a remote evaluation was to be preferred. Real world data (RWD) in the form of patient-reported outcomes (PROMs) and patient reported experiences (PREMs) were collected from patients who underwent televisit/teleconsultation through the eHealth platform. Results: During the lockdown period (from 8 March to 4 May 2020) a total of 1956 visits were managed. A total of 983 (50.26%) of these visits were performed via email (to apply for and to upload of documents) and phone call management; 31 visits (1.58%) were performed using the eHealth system. Substantially, all patients found the eHealth platform useful and user-friendly, consistently indicating that this type of service would also be useful after the pandemic. Conclusions: The rapid implementation of an eHealth system was feasible and well-accepted by the patients during the pandemic. However, we believe that further evidence is to be generated to further support large-scale adoption.

Keywords